Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniela Pollutri
Observed names:
D. Pollutri,
Daniela de Pollutri,
Pollutri, Daniela <1982>
Institution:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Observed institutions:
The University of Texas MD Anderson Cancer Center,
Thomas Jefferson University,
University of Ferrara,
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Sidney Kimmel Cancer Center,
Bolu Abant İzzet Baysal University,
University of Bologna
show all 7
ORCID:
0000-0002-7895-5128
Observed ORCID:
0000-0002-7895-5128
OpenAlex ID:
A5015039934
Works
44
Awards
1
MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
2010
·
Francesca Fornari
, Maddalena Milazzo
, et al.
·
Cancer Research
·
422
In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis
2017
·
Francesca Fornari
, Daniela Pollutri
, et al.
·
Clinical Cancer Research
·
171
PDF
Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC
2015
·
Francesca Fornari
, Manuela Ferracin
, et al.
·
PLoS ONE
·
159
PDF
The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma
2018
·
Daniela Pollutri
, Clarissa Patrizi
, et al.
·
Cell Death and Disease
·
93
PDF
MiR-30e-3p Influences Tumor Phenotype through MDM2 / TP53 Axis and Predicts Sorafenib Resistance in Hepatocellular Carcinoma
2020
·
Laura Gramantieri
, Daniela Pollutri
, et al.
·
Cancer Research
·
85
PDF
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
2019
·
Cristian Turato
, Francesca Fornari
, et al.
·
Journal of Clinical Medicine
·
47
PDF
TP53/MicroRNA Interplay in Hepatocellular Carcinoma
2016
·
Daniela Pollutri
, Laura Gramantieri
, et al.
·
International Journal of Molecular Sciences
·
41
PDF
Involvement of miR-30a-5p and miR-30d in Endothelial to Mesenchymal Transition and Early Osteogenic Commitment under Inflammatory Stress in HUVEC
2021
·
Carmen Ciavarella
, Ilenia Motta
, et al.
·
Biomolecules
·
36
PDF
Ribosomal Protein L10: From Function to Dysfunction
2020
·
Daniela Pollutri
, Marianna Penzo
·
Cells
·
33
PDF
JHDM1B expression regulates ribosome biogenesis and cancer cell growth in a p53 dependent manner
2014
·
Marianna Penzo
, Lucia Casoli
, et al.
·
International Journal of Cancer
·
24
Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman–Diamond syndrome cells
2023
·
Marco Cipolli
, Christian Boni
, et al.
·
British Journal of Haematology
·
19
Mutational analysis of ribosomal proteins in a cohort of pediatric patients with T-cell acute lymphoblastic leukemia reveals Q123R, a novel mutation in RPL10
2022
·
Lorenza Bacci
, Valentina Indio
, et al.
·
Frontiers in Genetics
·
6
Ribosomal protein L5 (RPL5/uL18) I60V mutation is associated to increased translation and modulates drug sensitivity in T-cell acute lymphoblastic leukemia cells
2025
·
Lorenza Bacci
, Daniela Pollutri
, et al.
·
Biochemical Pharmacology
·
3
In hepatocellular carcinoma miR-494 up-regulates the AKT/mTOR pathway and is involved in Sorafenib resistance
2016
·
D. Pollutri
, C. Patrizi
, et al.
·
Digestive and Liver Disease
·
3
Master of disguise: ribosomal protein L5 beyond translation
2025
·
Guglielmo Rambaldelli
, Lorenza Bacci
, et al.
·
Biochimie
·
2
Naphthalene-Based Aromatic Copolyesters Containing Polar Units with Improved Wettability and High Transparency for Biomedical Applications
2026
·
Alessandra Perrucci
, Daniela Pollutri
, et al.
·
Polymers
·
1
miR-6850 drives phenotypic changes and signaling in high grade serous ovarian cancer
2025
·
Kamil Filipek
, Daniela Pollutri
, et al.
·
Non-coding RNA Research
·
1
Data from MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
2023
·
Francesca Fornari
, Maddalena Milazzo
, et al.
·
1
Leveraging RB status to define therapy for castrate-resistant prostate cancer.
2014
·
Renee de Leeuw
, Clay de Comstock
, et al.
·
Journal of Clinical Oncology
·
1
Data from MiR-30e-3p Influences Tumor Phenotype through MDM2/TP53 Axis and Predicts Sorafenib Resistance in Hepatocellular Carcinoma
2023
·
Laura Gramantieri
, Daniela Pollutri
, et al.
Supplementary Tables from MiR-30e-3p Influences Tumor Phenotype through MDM2/TP53 Axis and Predicts Sorafenib Resistance in Hepatocellular Carcinoma
2023
·
Laura Gramantieri
, Daniela Pollutri
, et al.
Supplementary Figures from MiR-30e-3p Influences Tumor Phenotype through MDM2/TP53 Axis and Predicts Sorafenib Resistance in Hepatocellular Carcinoma
2023
·
Laura Gramantieri
, Daniela Pollutri
, et al.
Supplementary Material from MiR-30e-3p Influences Tumor Phenotype through MDM2/TP53 Axis and Predicts Sorafenib Resistance in Hepatocellular Carcinoma
2023
·
Laura Gramantieri
, Daniela Pollutri
, et al.
Supplementary Figure S3 from In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis
2023
·
Francesca Fornari
, Daniela Pollutri
, et al.
Supplemetary Figure S4 from In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis
2023
·
Francesca Fornari
, Daniela Pollutri
, et al.
Show more works
View as search
Works count:
44
Citation count:
1,148
H-index:
11
I10-index:
11
Year
Topic
Type